Glenn Braunstein: Research highlights from 2022

We were delighted to speak with our editorial board member Prof. Glenn Braunstein (Cedars-Sinai Medical Center, Los Angeles, CA, USA) around this year’s research highlights in thyroid disorders and what to look out for in 2023. Questions What are the key clinical highlights from 2022 in the field of thyroid disorders? (0:14) What are the […]

Current evidence indicates cardio‐metabolic effects from antithyroid drugs and other definitive treatment options for hyperthyroidism. The EGRET study aimed to assess the differences in mortality and cardiometabolic outcomes depending on the method of treatment in order to better inform patient‐clinician decision‐making. In this touchENDOCRINOLOGY interview, Prof. Kristien Boelaert (University of Birmingham, Birmingham, United Kingdom) discusses […]

Hyperthyroidism, also called overactive thyroid, occurs when your thyroid gland overproduces thyroid hormones. In this touchENDOCRINOLOGY interview, Prof. Kristien Boelaert (University of Birmingham, Birmingham, United Kingdom) discusses the challenges faced in the long term treatment of hyperthyroidism. The abstract entitled: ‘LONG‐TERM MORTALITY AND CARDIOMETABOLIC EFFECTS OF TREATMENT FOR HYPERTHYROIDISM: EGRET STUDY‘ was presented at the American […]